Related Experiment Video
Updated: Aug 13, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Millet shell polyphenols ameliorate atherosclerosis development by suppressing foam cell formation
Fengming Liu1, Shuhua Shan1, Hanqing Li2
1Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, Shanxi, China.
Millet shell polyphenols (MSPs) prevent atherosclerosis by inhibiting foam cell formation in macrophages and smooth muscle cells. MSPs also increase beneficial HDL-C in ApoE-/- mice, offering a strategy for cardiovascular disease prevention.
Area of Science:
- Cardiovascular Science
- Nutraceuticals
- Molecular Biology
Background:
- Polyphenols are plant-derived bioactive compounds utilized for disease prevention.
- Atherosclerosis is a cardiovascular disease characterized by plaque formation.
- Foam cell formation is a critical early event in atherosclerosis.
Purpose of the Study:
- To investigate the effects of millet shell polyphenols (MSPs) on preventing atherosclerosis.
- To elucidate the molecular mechanisms by which MSPs inhibit foam cell formation.
Main Methods:
- In vitro studies on macrophages and HASMCs.
- Analysis of inflammatory factor secretion (IL-1β, TNF-α).
- Assessment of STAT3 and NF-κB expression.
- Gene expression analysis of SMMHC, DES, SMTN, and ELN.
- In vivo experiments using ApoE-/- mice.
Main Results:
- MSPs inhibited lipid phagocytosis by macrophages and reduced IL-1β and TNF-α secretion via STAT3 and NF-κB pathways.
- MSPs hindered macrophage-derived foam cell formation.
- MSPs promoted HASMC transformation, inhibiting lipid phagocytosis and smooth muscle cell-derived foam cell formation.
- MSPs increased HDL-C levels in ApoE-/- mice.
Conclusions:
- MSPs effectively prevent atherosclerosis by impeding foam cell production through multiple cellular mechanisms.
- MSPs represent a potential therapeutic strategy for early-stage cardiovascular disease prevention.
- This study provides an integrative approach for thwarting atherosclerotic plaque formation.
Related Concept Videos
Atherosclerosis III: Management
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

